학술논문
Multicentre phase II trial of cabozantinib in patients with hepatocellular carcinoma after immune checkpoint inhibitor treatment
Document Type
Article
Author
Source
In Journal of Hepatology March 2024
Subject
Language
ISSN
0168-8278